BridgeBio Pharma (BBIO) Assets Growth (3y) (2021 - 2026)
BridgeBio Pharma (BBIO) Assets Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.89% |
| Dec 31, 2025 | 14.53% |
| Sep 30, 2025 | 11.06% |
| Jun 30, 2025 | 7.80% |
| Mar 31, 2025 | 2.73% |
| Dec 31, 2024 | -3.18% |
| Sep 30, 2024 | -5.24% |
| Jun 30, 2024 | -9.77% |
| Mar 31, 2024 | -8.07% |
| Dec 31, 2023 | -8.08% |
| Sep 30, 2023 | -5.96% |
| Jun 30, 2023 | -17.75% |
| Mar 31, 2023 | -14.18% |
| Dec 31, 2022 | -0.46% |
| Sep 30, 2022 | 4.39% |
| Jun 30, 2022 | 628.30% |
| Dec 31, 2021 | 707.71% |
| Sep 30, 2021 | 645.53% |
| Jun 30, 2021 | 730.79% |